期刊文献+

磁响应性水凝胶在肿瘤诊断和治疗中的应用研究进展

Progress on Application of Magnetic Response Hydrogel in Cancer Diagnosis and Treatment
原文传递
导出
摘要 肿瘤的早期诊断与微创治疗是目前研究的热点与难点。磁响应性水凝胶由于快速的磁响应、良好的生物相容性以及非侵入性远程致动等特性而在生物医学中具有广阔的应用前景,结合其独有的成像增强、磁导航性、磁热效应等特性,在肿瘤的诊断和治疗中受到了广泛关注。全文总结了磁响应性水凝胶的合成方法,重点介绍磁响应性水凝胶在肿瘤诊断与治疗中的研究和应用进展,并结合3D打印与微纳米机器人等技术对应用前景进行了展望,旨在为磁响应水凝胶在肿瘤方面的应用推广提供思路。 Early diagnosis and minimally invasive treatment of cancer are currently hot and challenging research topics.Magnetic responsive hydrogels have broad application prospects in biomedicine due to their fast magnetic response,good biocompatibility,non-invasive remote actuation and other characteristics.Combined with their unique imaging enhancement,magnetic navigation,magnetocaloric effect and other characteristics,they have received extensive attention in cancer diagnosis and treatment.This paper summarizes the synthesis methods of magnetic responsive hydrogels;reviews the research progress on their application in cancer diagnosis and treatment;and discusses the application prospects of this novel material in combination with 3D printing and nanorobot technology,aiming to provide ideas for the application of magnetic responsive hydrogels in cancer diagnosis and treatment.
作者 何进伟 周栋 HE Jinwei;ZHOU Dong(The Second Hospital of Lanzhou University,Lanzhou 730030,China)
出处 《肿瘤学杂志》 CAS 2024年第2期151-156,共6页 Journal of Chinese Oncology
基金 甘肃省自然科学基金项目(21JR11RA121,20JR10RA721)。
关键词 磁性纳米颗粒 磁响应性 水凝胶 肿瘤诊断 肿瘤治疗 magnetic nanoparticles magnetic responsiveness hydrogel tumor diagnosis tumor treatment
  • 相关文献

参考文献3

二级参考文献38

  • 1Mamede, A. C.; Tavares, S. D.; Abrantes, A. M.; Trindade, J.; Maia, J. M.; Botelho, M. F. The role of vitamins in cancer: A review. Nutr. Cancer 2011, 63, 479~494.
  • 2Russell-Jones, G.; McTavish, K.; McEwan, J.; Rice, J.; Nowotnik, D. Vitamin-mediated targeting as a potential mechanism to increase drug uptake by mmours. 31 lnorg. Biochem. 2004, 98, 1625 1633.
  • 3Giancaspero, T. A.; Busco, G.; Panebianco, C.; Carmone, C.; Miccolis, A.; Liuzzi, G. M.; Colella, M.; Barile, M. FAD synthesis and degradation in the nucleus create a local flavin cofactor pool. J. Biol. Chem. 2013, 288, 2906%29080.
  • 4Becker, K.; Schirmer, M.; Kanzok, S.; Schirmer, R. H. Flavins and flavoenzymes in diagnosis and therapy. In Flavoprotein Protocols; Chapman, S. K.; Reid, G. A., Eds.; Humana Press: Totowa, N.J., 1999; pp 229 245.
  • 5Rao, P. N.; Levine, E.; Myers, M. O.; Prakash, V.; Watson, J. Stolier, A.; Kopicko, J, J.; Kissinger, P.; Raj, S. G.; Raj, M. H Elevation of serum riboflavin carrier protein in breast cancer Cancer Epidemiol. Biomarkers Prev. 1999, 8, 985-990.
  • 6Bareford, L. M.; Swaan, P. W. Endocytic mechanisms for targeted drug delivery. Adv. Drug Deliv. Rev. 2007, 59, 748-758.
  • 7Bareford, L. M.; Avaritt, B. R.; Ghandehari, H.; Nan, A.; Swaan, P. W. Riboflavin-targeted polymer conjugates for breast tumor delivery. Pharm. Res. 2013, 30, 1799-1812.
  • 8Huang, S. N.; Phelps, M. A.; Swaan, P. W. Involvement of endocytie organelles in the subcellular trafficking and localization of riboflavin. J. Pharma~ol. Exp. Ther. 2003, 306, 681-687.
  • 9Pedrolli, D. B.; Jankowitsch, F.; Schwarz, J.; Langer, S.; Nakanishi, S.; Frei, E.; Mack, M. Riboflavin analogs as antiinfectives: Occurrence, mode of action, metabolism and resistance. Curr. Pharm. Des. 2013, 19, 2552-2560.
  • 10Chen, C.; Ke, J. Y.; Zhou, X. E.; Yi, W.; Brunzelle, J. S.; Li, J.; Yong, E. L.; Xu, H. E.; Melcher, K. Structural basis for molecular recognition of folio acid by folate receptors. Nature 2013, 500, 486-489.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部